NasdaqGM:YI

Stock Analysis Report

Executive Summary

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China.

Snowflake

Fundamentals

Adequate balance sheet with limited growth.


Similar Companies

Share Price & News

How has 111's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-6.0%

YI

-0.0006%

US Consumer Retailing

0.4%

US Market


1 Year Return

-47.1%

YI

14.4%

US Consumer Retailing

6.9%

US Market

Return vs Industry: YI underperformed the US Consumer Retailing industry which returned 14.4% over the past year.

Return vs Market: YI underperformed the US Market which returned 6.9% over the past year.


Shareholder returns

YIIndustryMarket
7 Day-6.0%-0.0006%0.4%
30 Day4.0%1.3%-1.2%
90 Day3.3%5.5%-0.4%
1 Year-47.1%-47.1%16.6%14.4%9.3%6.9%
3 Yearn/a56.5%46.5%45.8%36.4%
5 Yearn/a69.0%50.7%62.9%45.1%

Price Volatility Vs. Market

How volatile is 111's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is 111 undervalued compared to its fair value and its price relative to the market?

2.62x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: YI ($4.7) is trading above our estimate of fair value ($2.08)

Significantly Undervalued: YI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: YI is unprofitable, so we can't compare its PE Ratio to the Consumer Retailing industry average.

PE vs Market: YI is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate YI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: YI is overvalued based on its PB Ratio (2.6x) compared to the US Consumer Retailing industry average (2.1x).


Next Steps

Future Growth

How is 111 forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

71.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: YI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: YI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: YI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: YI's revenue (60.1% per year) is forecast to grow faster than the US market (7.2% per year).

High Growth Revenue: YI's revenue (60.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: YI is forecast to be unprofitable in 3 years.


Next Steps

Past Performance

How has 111 performed over the past 5 years?

-84.7%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: YI is unprofitable, and there is insufficient past data to establish if their past 5-year earnings growth rate was positive.

Accelerating Growth: Unable to compare YI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: YI is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (-14.2%).


Return on Equity

High ROE: YI has a negative Return on Equity (-45.57%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: YI is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: YI is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is 111's financial position?


Financial Position Analysis

Short Term Liabilities: YI's short term assets (CN¥1.6B) exceeds its short term liabilities (CN¥655.9M)

Long Term Liabilities: YI's short term assets (1.6B) exceeds its long term liabilities (46.9M)


Debt to Equity History and Analysis

Debt Level: YI's debt to equity ratio (3.6%) is considered satisfactory

Reducing Debt: Insufficient data to determine if YI's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: YI has a high level of physical assets or inventory.

Debt Coverage by Assets: YI's debt is covered by short term assets (assets are 44.182610x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: YI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if YI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is 111's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.7%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate YI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate YI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if YI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if YI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of YI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of 111's salary, the management and board of directors tenure and is there insider trading?

0.9yrs

Average management tenure


CEO

Junling Liu (54yo)

4.8yrs

Tenure

0

Mr. Junling Liu is Co-founder of 111, Inc. and has been its Chairman and Chief Executive Officer since 2015. Mr. Liu has been Co-Chairman of 111, Inc. since September 2018. He serves as Strategic Advisor a ...


Management Age and Tenure

0.9yrs

Average Tenure

54yo

Average Age

Experienced Management: YI's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Age and Tenure

1.1yrs

Average Tenure

54yo

Average Age

Experienced Board: YI's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Junling Liu (54yo)

    Co-Founder

    • Tenure: 4.8yrs
  • Gang Yu (60yo)

    Co-founder & Co-Chairman

    • Tenure: 4.8yrs
  • Luke Chen (48yo)

    Chief Financial Officer

    • Tenure: 0.7yrs
  • Haihui Wang

    Co-Chief Operating Officer

    • Tenure: 0.9yrs
  • Pengcheng Zhu

    Co-Chief Operating Officer

    • Tenure: 0.9yrs

Board Members

  • Junling Liu (54yo)

    Co-Founder

    • Tenure: 4.8yrs
  • David Sun (54yo)

    Independent Director

    • Tenure: 1.1yrs
  • Gang Yu (60yo)

    Co-founder & Co-Chairman

    • Tenure: 4.8yrs
  • Jun Luo (51yo)

    Independent Director

    • Tenure: 1.1yrs
  • Leon Lian Chen

    Director

    • Tenure: 0.4yrs
  • Nee Chuan Teo (48yo)

    Independent Director

    • Tenure: 1.1yrs

Company Information

111, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: 111, Inc.
  • Ticker: YI
  • Exchange: NasdaqGM
  • Founded: 2012
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: US$383.796m
  • Shares outstanding: 81.66m
  • Website: https://www.111.com.cn

Location

  • 111, Inc.
  • No. 295 ZuChongZhi Road
  • 3-5 Floors
  • Shanghai
  • 201203
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
YINasdaqGM (Nasdaq Global Market)YesADSUSUSDSep 2018

Biography

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/19 00:47
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.